SCHEMBL15545569

SCHEMBL15545569

O=C1CCc2cc(OC3CCNCC3)ccc2N1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.50
MAOB P27338 5/20 0.50
HRH3 Q9Y5N1 3/20 0.48
KIF11 P52732 1/20 0.47
ROCK1 Q13464 3/20 0.47
ROCK2 O75116 1/20 0.47
PRKACA P17612 1/20 0.47
PRKCD Q05655 1/20 0.47
PRKG1 Q13976 1/20 0.47
PKN1 Q16512 1/20 0.47
PKN2 Q16513 1/20 0.47
AAK1 Q2M2I8 1/20 0.47
CDC42BPA Q5VT25 1/20 0.47
Q6ZSR9 Q6ZSR9 1/20 0.47
BMP2K Q9NSY1 1/20 0.47
CDC42BPB Q9Y5S2 1/20 0.47
TIPARP Q7Z3E1 1/20 0.45
PKM P14618 1/20 0.44
HRH1 P35367 1/20 0.44
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4184334 0.89 CA9 (0.51) MAOAMAOBHRH3ROCK1ROCK2
SCHEMBL29594795 0.89 CA9 (0.51) MAOAMAOBHRH3ROCK1ROCK2
SCHEMBL2235364 0.87 PDE3B (0.52) MAOAMAOBKIF11PKMCYP1A2
SCHEMBL15546435 0.86 MAOA (0.52) MAOAMAOBKIF11PKMCYP1A2
SCHEMBL1991232 0.80 MAOA (0.56) MAOAMAOBHRH3CYP1A2CYP3A4
SCHEMBL15532807 0.80 CRBN (0.47) MAOAMAOBHRH3KIF11PDE3B
SCHEMBL426567 0.80 HRH3 (0.57) MAOAMAOBHRH3
SCHEMBL23143507 0.79 EIF2AK2 (0.60) HRH3ROCK1ROCK2PRKACAPRKCD
SCHEMBL29899578 0.79 EIF2AK2 (0.60) HRH3ROCK1ROCK2PRKACAPRKCD
SCHEMBL29754348 0.77 CA9 (0.54) MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017112719-A1 6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRIDIN-5-ONE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR MERCK SHARP & DOHME CORP. (US) 2017-06-29 WO disclosed
WO-2013170072-A2 COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS NEUROP, INC. (US) 2013-11-14 WO disclosed
WO-2013170072-A2 COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS NEUROP, INC. (US) 2013-11-14 WO disclosed